Peluso Stephane 4
4 · INFINITY PHARMACEUTICALS, INC. · Filed Aug 4, 2022
Insider Transaction Report
Form 4
Peluso Stephane
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2022-08-02+50,000→ 52,046 total - Sale
Common Stock
2022-08-02$0.66/sh+14,994$9,932→ 37,052 total - Exercise/Conversion
Restricted Stock Unit
2022-08-02−50,000→ 0 total→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Restricted stock units ("RSUs") convert into Common Stock of the issuer on a one-for-one basis. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date.
- [F2]Represents the shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of the RSUs listed in Table II. This sale does not represent a discretionary trade by the reporting person.
- [F3]On August 2, 2021, the reporting person was granted RSUs, of which all 50,000 vested as of August 2, 2022.